White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
YKTS (YKTS) currently trades at €21.20, while our model-based Fair Value estimate is €20.07, so the stock looks roughly fairly valued today (gap 5.6%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of €52.47 per share, and 4 of the 12 models we run sit above the €21.20 price.
Bear case: the Economic Profit group reads lowest at €7.38, and 8 of the 12 models stay below the price. Evidence for this calculation is medium.
Scenario range: €11.19 (bear) to €22.72 (bull), the price of €21.20 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Real Estate sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
YKTS reported revenue of €3.5M in FY2025 versus €514K in FY2021, a compound +62.0%/yr. Reported net income was €333K in FY2025.
Key figures
Market cap €40.4M · P/E ratio 123.5 · P/S ratio 11.6 · Net margin 9.4% · Return on assets (EBIT) −0.3% · Free cash flow €3.2M · Net debt €10.1M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 20% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −19% fair-value upside, at −5%, YKTS screens cheaper than that median.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF
€27.29
€44.54
€98.35
69
Growth DCF
€25.34
€52.47
€96.18
69
5Y EBITDA Exit
€7.71
€12.67
€22.21
68
All 12 models by family
DCF Models
FCF DCF
€27.29
€44.54
€98.35
69
5Y Revenue Exit
€6.04
€9.28
€15.69
66
5Y EBITDA Exit
€7.71
€12.67
€22.21
68
10Y Revenue Exit
€12.52
€22.48
€25.52
63
10Y EBITDA Exit
€13.80
€26.01
€43.95
61
Multiples
P/S Multiple
€2.25
€3.00
€3.75
58
P/B Multiple
€2.25
€3.00
€3.75
55
EV/EBIT
n/a
€0.1600
>€0.6400
61
EV/EBITDA
n/a
€1.20
€2.67
62
Asset-Based
NCAV (Graham)
€5.80
€7.77
€11.60
54
Growth DCF
Growth DCF
€25.34
€52.47
€96.18
69
Economic Profit
Residual Income
€7.91
€7.38
€5.49
66
Open the full fair value analysis →
Overall quality
46/100
Of which business quality 50
· Market factors (momentum, volatility) 69
Profitability
20
Margins and returns on capital today
Quality Growth
43
Are margins and returns improving?
Cashflow
100
Earnings quality: real cash, not paper profit
Fin. Strength
41
Balance sheet, leverage, solvency risk
Investment
49
Disciplined investing over empire-building
Low Volatility
100
Calm price path (market factor)
Momentum
46
Price trend over the last 3–12 months (market factor)
52W Momentum
73
Distance to the 52-week high (market factor)
Net Issuance
40
Share count: buybacks or dilution?
Open the full quality analysis →
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
10 more REITs stocks, each showing price versus our Fair Value estimate.
Pick a strategy and jump into the live analysis with that exact screen applied.
Is YKTS overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €20.07 versus a price of €21.20, about −5% upside (fairly valued).
What is the fair value of YKTS?
Our model-based fair value for YKTS is €20.07 (as of Sep 23, 2026), built from audited fundamentals. The current price: €21.20.
What is the quality score of YKTS?
YKTS has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for YKTS?
Our model-based price target is the fair value of €20.07 (as of Sep 23, 2026) from 12 valuation models. Cautious scenario €11.19, optimistic scenario €22.72. It is a calculation from audited fundamentals, not an analyst target.
What is the YKTS stock forecast for 2026?
Our models put fair value at €20.07, about −5% upside versus a price of €21.20 (fairly valued). Cautious scenario €11.19, optimistic scenario €22.72. The calculation is refreshed regularly with new filings.
What growth is priced into YKTS?
For today's price to be fair in a discounted-cash-flow model, YKTS would have to grow free cash flow by +8.3 % per year for five years (discount rate 11.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +62.0 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of YKTS use?
Our models discount YKTS at 11.1 %: a base by market capitalisation (nano), country premium for Spain. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For YKTS that is +8.3 % per year a year over ten years, using the same discount rate (11.1 %) and the same formula as our fair value.
How much growth has YKTS delivered so far?
Over the past 4 years revenue at YKTS grew +62.0 % a year. The price currently implies +8.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of YKTS?
The free-cash-flow yield on the price is 7.94 %: that much free cash flow YKTS produces per unit of market value. When it exceeds the discount rate of our models (11.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of YKTS?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For YKTS it is €20.07 per share (as of Sep 23, 2026), against a price of €21.20. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is YKTS stock overvalued or undervalued in 2026?
As of Sep 23, 2026, YKTS trades above its calculated fair value: price €21.20, fair value €20.07, a gap of about −5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of YKTS?
No. The price is what the market pays today (€21.20); the fair value is what the company's own numbers justify (€20.07). For YKTS the two are €1.13 per share apart. That gap is exactly why we show both numbers side by side.
How much is YKTS worth?
The market values YKTS at about €40.4M (market capitalisation, as of Sep 23, 2026). Per share that is €21.20; our models calculate a fair value of €20.07 per share.
What do the bullish and bearish scenarios say about YKTS?
Our models span a range for YKTS: cautious scenario €11.19, base €20.07, optimistic €22.72 per share (as of Sep 23, 2026, price €21.20). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of YKTS?
YKTS trades at a price-to-earnings ratio of 123.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €20.07 is built from several models across several years. Other multiples: P/B 2.1.
How solid is the balance sheet of YKTS?
Balance-sheet figures for YKTS (as of Sep 23, 2026): debt of 0.67 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is YKTS from its 52-week high?
YKTS trades at €21.20, at its 52-week high of €21.20 and 20% above the low of €17.70 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of €20.07 is for.
Which stocks are comparable to YKTS?
From the same area (Real Estate) we also value MFC-Nichada Thani Property Fund 2, ISSARA, Welltower Inc, Equinix, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is YKTS stock attractive at the current price?
The data as of Sep 23, 2026: price €21.20, calculated fair value €20.07 (−5%), Quality Score 46/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of YKTS calculated?
We run YKTS through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €20.07, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9 % above its aggregate fair value. YKTS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on
is it worth investing now.
What is the share price of YKTS?
The closing price on Sep 25, 2026 was €21.20. Our model-based fair value is €20.07, about −5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with YKTS right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (€11.19 to €22.72) leaves room in how you read the outcome. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Key figures of YKTS
How large is the market capitalisation of YKTS?
The market capitalisation of YKTS is €40.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of YKTS?
The price-to-sales ratio of YKTS is 11.6 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of YKTS?
The net margin of YKTS is 9.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of YKTS?
On an EBIT basis the return on assets of YKTS is −0.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net debt does YKTS carry?
The net debt of YKTS is €10.1M (fiscal year 2025, ≈ 3.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.